Plasma vascular endothelial growth factor and serum soluble angiopoietin receptor sTIE-2 in patients with dural arteriovenous fistulas: a pilot study
Our aim was to correlate concentrations of circulating vascular endothelial growth factor (VEGF) and serum soluble angiopoietin receptor (sTIE-2) before and after endovascular treatment with the grading in human dural arteriovenous fistulas (DAVFs). In ten patients with DAVFs undergoing diagnostic c...
Gespeichert in:
| Veröffentlicht in: | Neuroradiology 2005, Vol.47 (1), p.10-17 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 17 |
|---|---|
| container_issue | 1 |
| container_start_page | 10 |
| container_title | Neuroradiology |
| container_volume | 47 |
| creator | KLISCH, Joachim KUBALEK, Ralf SCHEUFLER, Kai M ZIRRGIEBEL, Ute DREVS, Joachim SCHUMACHER, Martin |
| description | Our aim was to correlate concentrations of circulating vascular endothelial growth factor (VEGF) and serum soluble angiopoietin receptor (sTIE-2) before and after endovascular treatment with the grading in human dural arteriovenous fistulas (DAVFs). In ten patients with DAVFs undergoing diagnostic cerebral angiography and endovascular intervention, pre-treatment and post-treatment levels of plasma VEGF and serum TIE-2 were examined in a prospective study design. A total of 32 plasma samples and 19 serum samples was collected from the cubital vein, the arterial sheath before and--if applicable--after intervention. Plasma VEGF and serum Tie-2 levels were measured by standardized ELISA protocols. In eight of ten patients with DAVF increased circulating VEGF levels (elevation of more than mean + 2 SD of published normal values) were found, whereas two patients showed increased sTIE-2 levels. Six of the seven patients treated by endovascular embolization displayed a post-interventional decrease of VEGF values. The serum TIE-2 levels decreased slightly after intervention. Pre-treatment vVEGF levels varied significantly between patients with grades I and II/III fistulas according to the Cognards classification system. Our pilot study suggests that assessment of angiogenesis parameters in patients with DAVFs might correlate with the DAVFs' grade. To support the hypothesis that a change in angiogenic indicators may serve as indicators for a response to therapy, a larger number of patients should be followed for a longer time period. |
| doi_str_mv | 10.1007/s00234-004-1310-3 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67416258</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67416258</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-54da79826deac4a1432131c67dad5d12f8de4d8a0289f437ddb8ecae64c0907d3</originalsourceid><addsrcrecordid>eNpdkd9qHSEQh6U0NCdpH6A3RQrN3bbj6v7rXQlpGwgkF-m1zNHZxOCuW3UT8iB533o4BwK9EvWbn-N8jH0U8FUAdN8SQC1VBaAqIQVU8g3bCCXrSgw1vGWbct1XclBwzE5SegAA2cnuHTsWTdtAL8WGvdx4TBPyR0xm9Rg5zTbke_IOPb-L4Snf8xFNDpHjbHmiuE48Bb9uPZWTOxeW4Ci7mUcytOy4dHt5UdW8HC2YHc058SdXYuwaSybGTNGFR5rDmvjoUi7Ppu8c-eJ8yLzs7fN7djSiT_ThsJ6yPz8vbs9_V1fXvy7Pf1xVRjZtrhplsRv6urWERuHu62UOpu0s2saKeuwtKdtjGcMwKtlZu-3JILXKwACdlafsbJ-7xPB3pZT15JIh73Gm0p5uOyXauukL-Pk_8CGscS696boWQg1DMxRI7CETQ0qRRr1EN2F81gL0TpjeC9NFmN4J07LUfDoEr9uJ7GvFwVABvhyAYgj9GHE2Lr1yrepAgpL_AOhaoNc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>221149959</pqid></control><display><type>article</type><title>Plasma vascular endothelial growth factor and serum soluble angiopoietin receptor sTIE-2 in patients with dural arteriovenous fistulas: a pilot study</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>KLISCH, Joachim ; KUBALEK, Ralf ; SCHEUFLER, Kai M ; ZIRRGIEBEL, Ute ; DREVS, Joachim ; SCHUMACHER, Martin</creator><creatorcontrib>KLISCH, Joachim ; KUBALEK, Ralf ; SCHEUFLER, Kai M ; ZIRRGIEBEL, Ute ; DREVS, Joachim ; SCHUMACHER, Martin</creatorcontrib><description>Our aim was to correlate concentrations of circulating vascular endothelial growth factor (VEGF) and serum soluble angiopoietin receptor (sTIE-2) before and after endovascular treatment with the grading in human dural arteriovenous fistulas (DAVFs). In ten patients with DAVFs undergoing diagnostic cerebral angiography and endovascular intervention, pre-treatment and post-treatment levels of plasma VEGF and serum TIE-2 were examined in a prospective study design. A total of 32 plasma samples and 19 serum samples was collected from the cubital vein, the arterial sheath before and--if applicable--after intervention. Plasma VEGF and serum Tie-2 levels were measured by standardized ELISA protocols. In eight of ten patients with DAVF increased circulating VEGF levels (elevation of more than mean + 2 SD of published normal values) were found, whereas two patients showed increased sTIE-2 levels. Six of the seven patients treated by endovascular embolization displayed a post-interventional decrease of VEGF values. The serum TIE-2 levels decreased slightly after intervention. Pre-treatment vVEGF levels varied significantly between patients with grades I and II/III fistulas according to the Cognards classification system. Our pilot study suggests that assessment of angiogenesis parameters in patients with DAVFs might correlate with the DAVFs' grade. To support the hypothesis that a change in angiogenic indicators may serve as indicators for a response to therapy, a larger number of patients should be followed for a longer time period.</description><identifier>ISSN: 0028-3940</identifier><identifier>EISSN: 1432-1920</identifier><identifier>DOI: 10.1007/s00234-004-1310-3</identifier><identifier>PMID: 15650831</identifier><identifier>CODEN: NRDYAB</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Aged ; Biological and medical sciences ; Central Nervous System Vascular Malformations - blood ; Central Nervous System Vascular Malformations - classification ; Central Nervous System Vascular Malformations - therapy ; Cerebral Angiography ; Ear, auditive nerve, cochleovestibular tract, facial nerve: diseases, semeiology ; Embolization, Therapeutic ; Female ; Follow-Up Studies ; Fundamental and applied biological sciences. Psychology ; Growth hormones ; Human ; Humans ; Investigative techniques, diagnostic techniques (general aspects) ; Learning. Memory ; Male ; Medical diagnosis ; Medical sciences ; Medical treatment ; Memory ; Middle Aged ; Nervous system ; Neurology ; Non tumoral diseases ; Otorhinolaryngology. Stomatology ; Pilot Projects ; Prospective Studies ; Psychology. Psychoanalysis. Psychiatry ; Psychology. Psychophysiology ; Radiodiagnosis. Nmr imagery. Nmr spectrometry ; Receptor, TIE-2 - blood ; Single-Blind Method ; Vascular Endothelial Growth Factor A - blood</subject><ispartof>Neuroradiology, 2005, Vol.47 (1), p.10-17</ispartof><rights>2005 INIST-CNRS</rights><rights>Springer-Verlag 2005</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-54da79826deac4a1432131c67dad5d12f8de4d8a0289f437ddb8ecae64c0907d3</citedby><cites>FETCH-LOGICAL-c356t-54da79826deac4a1432131c67dad5d12f8de4d8a0289f437ddb8ecae64c0907d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16470304$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15650831$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KLISCH, Joachim</creatorcontrib><creatorcontrib>KUBALEK, Ralf</creatorcontrib><creatorcontrib>SCHEUFLER, Kai M</creatorcontrib><creatorcontrib>ZIRRGIEBEL, Ute</creatorcontrib><creatorcontrib>DREVS, Joachim</creatorcontrib><creatorcontrib>SCHUMACHER, Martin</creatorcontrib><title>Plasma vascular endothelial growth factor and serum soluble angiopoietin receptor sTIE-2 in patients with dural arteriovenous fistulas: a pilot study</title><title>Neuroradiology</title><addtitle>Neuroradiology</addtitle><description>Our aim was to correlate concentrations of circulating vascular endothelial growth factor (VEGF) and serum soluble angiopoietin receptor (sTIE-2) before and after endovascular treatment with the grading in human dural arteriovenous fistulas (DAVFs). In ten patients with DAVFs undergoing diagnostic cerebral angiography and endovascular intervention, pre-treatment and post-treatment levels of plasma VEGF and serum TIE-2 were examined in a prospective study design. A total of 32 plasma samples and 19 serum samples was collected from the cubital vein, the arterial sheath before and--if applicable--after intervention. Plasma VEGF and serum Tie-2 levels were measured by standardized ELISA protocols. In eight of ten patients with DAVF increased circulating VEGF levels (elevation of more than mean + 2 SD of published normal values) were found, whereas two patients showed increased sTIE-2 levels. Six of the seven patients treated by endovascular embolization displayed a post-interventional decrease of VEGF values. The serum TIE-2 levels decreased slightly after intervention. Pre-treatment vVEGF levels varied significantly between patients with grades I and II/III fistulas according to the Cognards classification system. Our pilot study suggests that assessment of angiogenesis parameters in patients with DAVFs might correlate with the DAVFs' grade. To support the hypothesis that a change in angiogenic indicators may serve as indicators for a response to therapy, a larger number of patients should be followed for a longer time period.</description><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Central Nervous System Vascular Malformations - blood</subject><subject>Central Nervous System Vascular Malformations - classification</subject><subject>Central Nervous System Vascular Malformations - therapy</subject><subject>Cerebral Angiography</subject><subject>Ear, auditive nerve, cochleovestibular tract, facial nerve: diseases, semeiology</subject><subject>Embolization, Therapeutic</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Growth hormones</subject><subject>Human</subject><subject>Humans</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Learning. Memory</subject><subject>Male</subject><subject>Medical diagnosis</subject><subject>Medical sciences</subject><subject>Medical treatment</subject><subject>Memory</subject><subject>Middle Aged</subject><subject>Nervous system</subject><subject>Neurology</subject><subject>Non tumoral diseases</subject><subject>Otorhinolaryngology. Stomatology</subject><subject>Pilot Projects</subject><subject>Prospective Studies</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychology. Psychophysiology</subject><subject>Radiodiagnosis. Nmr imagery. Nmr spectrometry</subject><subject>Receptor, TIE-2 - blood</subject><subject>Single-Blind Method</subject><subject>Vascular Endothelial Growth Factor A - blood</subject><issn>0028-3940</issn><issn>1432-1920</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkd9qHSEQh6U0NCdpH6A3RQrN3bbj6v7rXQlpGwgkF-m1zNHZxOCuW3UT8iB533o4BwK9EvWbn-N8jH0U8FUAdN8SQC1VBaAqIQVU8g3bCCXrSgw1vGWbct1XclBwzE5SegAA2cnuHTsWTdtAL8WGvdx4TBPyR0xm9Rg5zTbke_IOPb-L4Snf8xFNDpHjbHmiuE48Bb9uPZWTOxeW4Ci7mUcytOy4dHt5UdW8HC2YHc058SdXYuwaSybGTNGFR5rDmvjoUi7Ppu8c-eJ8yLzs7fN7djSiT_ThsJ6yPz8vbs9_V1fXvy7Pf1xVRjZtrhplsRv6urWERuHu62UOpu0s2saKeuwtKdtjGcMwKtlZu-3JILXKwACdlafsbJ-7xPB3pZT15JIh73Gm0p5uOyXauukL-Pk_8CGscS696boWQg1DMxRI7CETQ0qRRr1EN2F81gL0TpjeC9NFmN4J07LUfDoEr9uJ7GvFwVABvhyAYgj9GHE2Lr1yrepAgpL_AOhaoNc</recordid><startdate>2005</startdate><enddate>2005</enddate><creator>KLISCH, Joachim</creator><creator>KUBALEK, Ralf</creator><creator>SCHEUFLER, Kai M</creator><creator>ZIRRGIEBEL, Ute</creator><creator>DREVS, Joachim</creator><creator>SCHUMACHER, Martin</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>2005</creationdate><title>Plasma vascular endothelial growth factor and serum soluble angiopoietin receptor sTIE-2 in patients with dural arteriovenous fistulas: a pilot study</title><author>KLISCH, Joachim ; KUBALEK, Ralf ; SCHEUFLER, Kai M ; ZIRRGIEBEL, Ute ; DREVS, Joachim ; SCHUMACHER, Martin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-54da79826deac4a1432131c67dad5d12f8de4d8a0289f437ddb8ecae64c0907d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Central Nervous System Vascular Malformations - blood</topic><topic>Central Nervous System Vascular Malformations - classification</topic><topic>Central Nervous System Vascular Malformations - therapy</topic><topic>Cerebral Angiography</topic><topic>Ear, auditive nerve, cochleovestibular tract, facial nerve: diseases, semeiology</topic><topic>Embolization, Therapeutic</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Growth hormones</topic><topic>Human</topic><topic>Humans</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Learning. Memory</topic><topic>Male</topic><topic>Medical diagnosis</topic><topic>Medical sciences</topic><topic>Medical treatment</topic><topic>Memory</topic><topic>Middle Aged</topic><topic>Nervous system</topic><topic>Neurology</topic><topic>Non tumoral diseases</topic><topic>Otorhinolaryngology. Stomatology</topic><topic>Pilot Projects</topic><topic>Prospective Studies</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychology. Psychophysiology</topic><topic>Radiodiagnosis. Nmr imagery. Nmr spectrometry</topic><topic>Receptor, TIE-2 - blood</topic><topic>Single-Blind Method</topic><topic>Vascular Endothelial Growth Factor A - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KLISCH, Joachim</creatorcontrib><creatorcontrib>KUBALEK, Ralf</creatorcontrib><creatorcontrib>SCHEUFLER, Kai M</creatorcontrib><creatorcontrib>ZIRRGIEBEL, Ute</creatorcontrib><creatorcontrib>DREVS, Joachim</creatorcontrib><creatorcontrib>SCHUMACHER, Martin</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Neuroradiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KLISCH, Joachim</au><au>KUBALEK, Ralf</au><au>SCHEUFLER, Kai M</au><au>ZIRRGIEBEL, Ute</au><au>DREVS, Joachim</au><au>SCHUMACHER, Martin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plasma vascular endothelial growth factor and serum soluble angiopoietin receptor sTIE-2 in patients with dural arteriovenous fistulas: a pilot study</atitle><jtitle>Neuroradiology</jtitle><addtitle>Neuroradiology</addtitle><date>2005</date><risdate>2005</risdate><volume>47</volume><issue>1</issue><spage>10</spage><epage>17</epage><pages>10-17</pages><issn>0028-3940</issn><eissn>1432-1920</eissn><coden>NRDYAB</coden><abstract>Our aim was to correlate concentrations of circulating vascular endothelial growth factor (VEGF) and serum soluble angiopoietin receptor (sTIE-2) before and after endovascular treatment with the grading in human dural arteriovenous fistulas (DAVFs). In ten patients with DAVFs undergoing diagnostic cerebral angiography and endovascular intervention, pre-treatment and post-treatment levels of plasma VEGF and serum TIE-2 were examined in a prospective study design. A total of 32 plasma samples and 19 serum samples was collected from the cubital vein, the arterial sheath before and--if applicable--after intervention. Plasma VEGF and serum Tie-2 levels were measured by standardized ELISA protocols. In eight of ten patients with DAVF increased circulating VEGF levels (elevation of more than mean + 2 SD of published normal values) were found, whereas two patients showed increased sTIE-2 levels. Six of the seven patients treated by endovascular embolization displayed a post-interventional decrease of VEGF values. The serum TIE-2 levels decreased slightly after intervention. Pre-treatment vVEGF levels varied significantly between patients with grades I and II/III fistulas according to the Cognards classification system. Our pilot study suggests that assessment of angiogenesis parameters in patients with DAVFs might correlate with the DAVFs' grade. To support the hypothesis that a change in angiogenic indicators may serve as indicators for a response to therapy, a larger number of patients should be followed for a longer time period.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>15650831</pmid><doi>10.1007/s00234-004-1310-3</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0028-3940 |
| ispartof | Neuroradiology, 2005, Vol.47 (1), p.10-17 |
| issn | 0028-3940 1432-1920 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67416258 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Aged Biological and medical sciences Central Nervous System Vascular Malformations - blood Central Nervous System Vascular Malformations - classification Central Nervous System Vascular Malformations - therapy Cerebral Angiography Ear, auditive nerve, cochleovestibular tract, facial nerve: diseases, semeiology Embolization, Therapeutic Female Follow-Up Studies Fundamental and applied biological sciences. Psychology Growth hormones Human Humans Investigative techniques, diagnostic techniques (general aspects) Learning. Memory Male Medical diagnosis Medical sciences Medical treatment Memory Middle Aged Nervous system Neurology Non tumoral diseases Otorhinolaryngology. Stomatology Pilot Projects Prospective Studies Psychology. Psychoanalysis. Psychiatry Psychology. Psychophysiology Radiodiagnosis. Nmr imagery. Nmr spectrometry Receptor, TIE-2 - blood Single-Blind Method Vascular Endothelial Growth Factor A - blood |
| title | Plasma vascular endothelial growth factor and serum soluble angiopoietin receptor sTIE-2 in patients with dural arteriovenous fistulas: a pilot study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T20%3A06%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plasma%20vascular%20endothelial%20growth%20factor%20and%20serum%20soluble%20angiopoietin%20receptor%20sTIE-2%20in%20patients%20with%20dural%20arteriovenous%20fistulas:%20a%20pilot%20study&rft.jtitle=Neuroradiology&rft.au=KLISCH,%20Joachim&rft.date=2005&rft.volume=47&rft.issue=1&rft.spage=10&rft.epage=17&rft.pages=10-17&rft.issn=0028-3940&rft.eissn=1432-1920&rft.coden=NRDYAB&rft_id=info:doi/10.1007/s00234-004-1310-3&rft_dat=%3Cproquest_cross%3E67416258%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=221149959&rft_id=info:pmid/15650831&rfr_iscdi=true |